{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:21:58Z","timestamp":1794489718781,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatoma is a common malignancy of the liver. The abnormal high expression of alpha-fetoprotein (AFP) is intimately associated with hepatoma progress, but the mechanism of transcriptional regulation and singularly activation of AFP gene in hepatoma is not clear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The expression of transcription factor HBP1 and AFP and clinical significance were further analyzed in hepatoma tissues from the patients who received surgery or TACE and then monitored for relapse for up 10\u2009years. HBP1-mediated transcriptional regulation of AFP was analyzed by Western blotting, Luciferase assay, Realtime-PCR, ChIP and EMSA. After verified the axis of HBP-AFP, its impact on hepatoma was measured by MTT, Transwell and FACS in hepatoma cells and by tumorigenesis in HBP1\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The relative expressions of HBP1 and AFP correlated with survival and prognosis in hepatoma patients. HBP1 repressed the expression of AFP gene by directly binding to the AFP gene promoter. Hepatitis B Virus (HBV)-encoded protein HBx promoted malignancy in hepatoma cells through binding to HBP1 directly. Icaritin, an active ingredient of Chinese herb epimedium, inhibited malignancy in hepatoma cells through enhancing HBP1 transrepression of AFP. The repression of AFP by HBP1 attenuated AFP effect on PTEN, MMP9 and caspase-3, thus inhibited proliferation and migration, and induced apoptosis in hepatoma cells. The deregulation of AFP by HBP1 contributed to hepatoma progression in mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data clarify the mechanism of HBP1 in inhibiting the expression of AFP and its suppression in malignancy of hepatoma cells, providing a more comprehensive theoretical basis and potential solutions for the diagnosis and treatment of hepatoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-021-01881-2","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T07:03:33Z","timestamp":1617260613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["HBP1-mediated transcriptional repression of AFP inhibits hepatoma progression"],"prefix":"10.1186","volume":"40","author":[{"given":"Zhengyi","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"1881_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/MCG.0b013e3182872f29","volume":"47","author":"S Mittal","year":"2013","unstructured":"Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol. 2013;47:2\u20136.","journal-title":"J Clin Gastroenterol"},{"key":"1881_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"1881_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.canlet.2013.08.035","volume":"345","author":"C Xu","year":"2014","unstructured":"Xu C, Zhou W, Wang Y, Qiao L. Hepatitis B virus-induced hepatocellular carcinoma. Cancer Lett. 2014;345:216\u201322.","journal-title":"Cancer Lett"},{"key":"1881_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000490360","volume":"8","author":"S Owusu Sekyere","year":"2019","unstructured":"Owusu Sekyere S, Schlevogt B, Mettke F, Kabbani M, Deterding K, Wirth TC, et al. HCC immune surveillance and antiviral therapy of hepatitis C virus infection. Liver Cancer. 2019;8:41\u201365.","journal-title":"Liver Cancer"},{"key":"1881_CR5","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1053\/j.gastro.2011.03.006","volume":"140","author":"A Villanueva","year":"2011","unstructured":"Villanueva A, Llovet JM. Targeted therapies for hepatocellular carcinoma. Gastroenterology. 2011;140:1410\u201326.","journal-title":"Gastroenterology."},{"key":"1881_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1158\/1078-0432.CCR-09-2084","volume":"16","author":"RS Finn","year":"2010","unstructured":"Finn RS. Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now? Clin Cancer Res. 2010;16:390\u20137.","journal-title":"Clin Cancer Res"},{"key":"1881_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cca.2016.10.006","volume":"463","author":"C Sauzay","year":"2016","unstructured":"Sauzay C, Petit A, Bourgeois AM, Barbare JC, Chauffert B, Galmiche A, et al. Alpha-foetoprotein (AFP): a multi-purpose marker in hepatocellular carcinoma. Clin Chim Acta. 2016;463:39\u201344.","journal-title":"Clin Chim Acta"},{"key":"1881_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/ijc.25373","volume":"128","author":"M Li","year":"2011","unstructured":"Li M, Li H, Li C, Wang S, Jiang W, Liu Z, et al. Alpha-fetoprotein: a new member of intracellular signal molecules in regulation of the PI3K\/AKT signaling in human hepatoma cell lines. Int J Cancer. 2011;128:524\u201332.","journal-title":"Int J Cancer"},{"key":"1881_CR9","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/ijc.24272","volume":"124","author":"M Li","year":"2009","unstructured":"Li M, Li H, Li C, Zhou S, Guo L, Liu H, et al. Alpha fetoprotein is a novel protein-binding partner for caspase-3 and blocks the apoptotic signaling pathway in human hepatoma cells. Int J Cancer. 2009;124:2845\u201354.","journal-title":"Int J Cancer"},{"key":"1881_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.canlet.2009.05.014","volume":"285","author":"M Li","year":"2009","unstructured":"Li M, Li H, Li C, Guo L, Liu H, Zhou S, et al. Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells. Cancer Lett. 2009;285:190\u20139.","journal-title":"Cancer Lett"},{"key":"1881_CR11","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/ijc.26025","volume":"130","author":"C Li","year":"2012","unstructured":"Li C, Wang S, Jiang W, Li H, Liu Z, Zhang C, et al. Impact of intracellular alpha fetoprotein on retinoic acid receptors-mediated expression of GADD153 in human hepatoma cell lines. Int J Cancer. 2012;130:754\u201364.","journal-title":"Int J Cancer"},{"key":"1881_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jhep.2012.03.029","volume":"57","author":"S Wang","year":"2012","unstructured":"Wang S, Jiang W, Chen X, Zhang C, Li H, Hou W, et al. Alpha-fetoprotein acts as a novel signal molecule and mediates transcription of Fn14 in human hepatocellular carcinoma. J Hepatol. 2012;57:322\u20139.","journal-title":"J Hepatol"},{"key":"1881_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jcmm.12745","volume":"20","author":"Y Lu","year":"2016","unstructured":"Lu Y, Zhu M, Li W, Lin B, Dong X, Chen Y, et al. Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells. J Cell Mol Med. 2016;20:549\u201358.","journal-title":"J Cell Mol Med"},{"key":"1881_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.18632\/oncoscience.115","volume":"2","author":"M Zhu","year":"2015","unstructured":"Zhu M, Guo J, Xia H, Li W, Lu Y, Dong X, et al. Alpha-fetoprotein activates AKT\/mTOR signaling to promote CXCR4 expression and migration of hepatoma cells. Oncoscience. 2015;2:59\u201370.","journal-title":"Oncoscience."},{"key":"1881_CR15","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1128\/MCB.24.7.3011-3024.2004","volume":"24","author":"SP Berasi","year":"2004","unstructured":"Berasi SP, Xiu M, Yee AS, Paulson KE. HBP1 repression of the p47phox gene: cell cycle regulation via the NADPH oxidase. Mol Cell Biol. 2004;24:3011\u201324.","journal-title":"Mol Cell Biol"},{"key":"1881_CR16","doi-asserted-by":"publisher","first-page":"8252","DOI":"10.1128\/MCB.00604-06","volume":"26","author":"X Zhang","year":"2006","unstructured":"Zhang X, Kim J, Ruthazer R, McDevitt MA, Wazer DE, Paulson KE, et al. The HBP1 transcriptional repressor participates in RAS-induced premature senescence. Mol Cell Biol. 2006;26:8252\u201366.","journal-title":"Mol Cell Biol"},{"key":"1881_CR17","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1128\/MCB.00637-12","volume":"33","author":"K Pan","year":"2013","unstructured":"Pan K, Chen Y, Roth M, Wang W, Wang S, Yee AS, et al. HBP1-mediated transcriptional regulation of DNA methyltransferase 1 and its impact on cell senescence. Mol Cell Biol. 2013;33:887\u2013903.","journal-title":"Mol Cell Biol"},{"key":"1881_CR18","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1074\/jbc.M109.074856","volume":"285","author":"JR Escamilla-Powers","year":"2010","unstructured":"Escamilla-Powers JR, Daniel CJ, Farrell A, Taylor K, Zhang X, Byers S, et al. The tumor suppressor protein HBP1 is a novel c-myc-binding protein that negatively regulates c-myc transcriptional activity. J Biol Chem. 2010;285:4847\u201358.","journal-title":"J Biol Chem"},{"key":"1881_CR19","doi-asserted-by":"publisher","first-page":"12688","DOI":"10.1074\/jbc.M116.714147","volume":"291","author":"Y Chen","year":"2016","unstructured":"Chen Y, Pan K, Wang P, Cao Z, Wang W, Wang S, et al. HBP1-mediated regulation of p21 protein through the Mdm2\/p53 and TCF4\/EZH2 pathways and its impact on cell senescence and tumorigenesis. J Biol Chem. 2016;291:12688\u2013705.","journal-title":"J Biol Chem"},{"key":"1881_CR20","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1038\/onc.2010.252","volume":"29","author":"H Li","year":"2010","unstructured":"Li H, Wang W, Liu X, Paulson KE, Yee AS, Zhang X. Transcriptional factor HBP1 targets P16 (INK4A), upregulating its expression and consequently is involved in Ras-induced premature senescence. Oncogene. 2010;29:5083\u201394.","journal-title":"Oncogene."},{"key":"1881_CR21","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1038\/sj.onc.1202240","volume":"17","author":"AL Gartel","year":"1998","unstructured":"Gartel AL, Goufman E, Tevosian SG, Shih H, Yee AS, Tyner AL. Activation and repression of p21 (WAF1\/CIP1) transcription by RB binding proteins. Oncogene. 1998;17:3463\u20139.","journal-title":"Oncogene."},{"key":"1881_CR22","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1038\/sj.leu.2403918","volume":"19","author":"CJ Yao","year":"2005","unstructured":"Yao CJ, Works K, Romagnoli PA, Austin GE. Effects of overexpression of HBP1 upon growth and differentiation of leukemic myeloid cells. Leukemia. 2005;19:1958\u201368.","journal-title":"Leukemia."},{"key":"1881_CR23","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1128\/MCB.20.18.6627-6637.2000","volume":"20","author":"C Lemercier","year":"2000","unstructured":"Lemercier C, Duncliffe K, Boibessot I, Zhang H, Verdel A, Angelov D, et al. Involvement of retinoblastoma protein and HBP1 in histone H1(0) gene expression. Mol Cell Biol. 2000;20:6627\u201337.","journal-title":"Mol Cell Biol"},{"key":"1881_CR24","doi-asserted-by":"publisher","first-page":"8890","DOI":"10.1128\/MCB.23.23.8890-8901.2003","volume":"23","author":"M Xiu","year":"2003","unstructured":"Xiu M, Kim J, Sampson E, Huang CY, Davis RJ, Paulson KE, et al. The transcriptional repressor HBP1 is a target of the p38 mitogen-activated protein kinase pathway in cell cycle regulation. Mol Cell Biol. 2003;23:8890\u2013901.","journal-title":"Mol Cell Biol"},{"key":"1881_CR25","doi-asserted-by":"publisher","first-page":"8207","DOI":"10.1074\/jbc.M116.768101","volume":"292","author":"S Wang","year":"2017","unstructured":"Wang S, Cao Z, Xue J, Li H, Jiang W, Cheng Y, et al. A positive feedback loop between Pim-1 kinase and HBP1 transcription factor contributes to hydrogen peroxide-induced premature senescence and apoptosis. J Biol Chem. 2017;292:8207\u201322.","journal-title":"J Biol Chem"},{"key":"1881_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/nar\/gkr818","volume":"40","author":"W Wang","year":"2012","unstructured":"Wang W, Pan K, Chen Y, Huang C, Zhang X. The acetylation of transcription factor HBP1 by p300\/CBP enhances p16INK4A expression. Nucleic Acids Res. 2012;40:981\u201395.","journal-title":"Nucleic Acids Res"},{"key":"1881_CR27","doi-asserted-by":"publisher","first-page":"e35528","DOI":"10.7554\/eLife.35528","volume":"7","author":"F Lampert","year":"2018","unstructured":"Lampert F, Stafa D, Goga A, Soste MV, Gilberto S, Olieric N, et al. The multi-subunit GID\/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation. Elife. 2018;7:e35528.","journal-title":"Elife."},{"key":"1881_CR28","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1038\/s41388-019-0761-2","volume":"38","author":"Z Cao","year":"2019","unstructured":"Cao Z, Xue J, Cheng Y, Wang J, Liu Y, Li H, et al. MDM2 promotes genome instability by ubiquitinating the transcription factor HBP1. Oncogene. 2019;38:4835\u201355.","journal-title":"Oncogene."},{"key":"1881_CR29","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1007\/s00535-011-0415-9","volume":"46","author":"SA Ng","year":"2011","unstructured":"Ng SA, Lee C. Hepatitis B virus X gene and hepatocarcinogenesis. J Gastroenterol. 2011;46:974\u201390.","journal-title":"J Gastroenterol"},{"key":"1881_CR30","doi-asserted-by":"publisher","first-page":"12196","DOI":"10.18632\/oncotarget.2906","volume":"6","author":"M Zhu","year":"2015","unstructured":"Zhu M, Guo J, Xia H, Li W, Lu Y, Dong X, et al. Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K\/mTOR signaling pathway in liver cells. Oncotarget. 2015;6:12196\u2013208.","journal-title":"Oncotarget."},{"key":"1881_CR31","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/ijc.29548","volume":"137","author":"C Zhang","year":"2015","unstructured":"Zhang C, Chen X, Liu H, Li H, Jiang W, Hou W, et al. Alpha fetoprotein mediates HBx induced carcinogenesis in the hepatocyte cytoplasm. Int J Cancer. 2015;137:1818\u201329.","journal-title":"Int J Cancer"},{"key":"1881_CR32","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.intimp.2011.01.007","volume":"11","author":"J Zhou","year":"2011","unstructured":"Zhou J, Wu J, Chen X, Fortenbery N, Eksioglu E, Kodumudi KN, et al. Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions. Int Immunopharmacol. 2011;11:890\u20138.","journal-title":"Int Immunopharmacol"},{"key":"1881_CR33","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1055\/s-0030-1250042","volume":"76","author":"J He","year":"2010","unstructured":"He J, Wang Y, Duan F, Jiang H, Chen MF, Tang SY. Icaritin induces apoptosis of HepG2 cells via the JNK1 signaling pathway independent of the estrogen receptor. Planta Med. 2010;76:1834\u20139.","journal-title":"Planta Med"},{"key":"1881_CR34","doi-asserted-by":"publisher","first-page":"31927","DOI":"10.18632\/oncotarget.5578","volume":"6","author":"H Zhao","year":"2015","unstructured":"Zhao H, Guo Y, Li S, Han R, Ying J, Zhu H, et al. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6\/Jak2\/Stat3 pathway. Oncotarget. 2015;6:31927\u201343.","journal-title":"Oncotarget."},{"key":"1881_CR35","doi-asserted-by":"publisher","first-page":"83755","DOI":"10.18632\/oncotarget.13194","volume":"7","author":"C Zhang","year":"2016","unstructured":"Zhang C, Li H, Jiang W, Zhang X, Li G. Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation. Oncotarget. 2016;7:83755\u201366.","journal-title":"Oncotarget."},{"key":"1881_CR36","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1128\/MCB.21.17.5723-5732.2001","volume":"21","author":"HH Shih","year":"2001","unstructured":"Shih HH, Xiu M, Berasi SP, Sampson EM, Leiter A, Paulson KE, et al. HMG box transcriptional repressor HBP1 maintains a proliferation barrier in differentiated liver tissue. Mol Cell Biol. 2001;21:5723\u201332.","journal-title":"Mol Cell Biol"},{"key":"1881_CR37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s00795-009-0457-8","volume":"42","author":"Y Matsuda","year":"2009","unstructured":"Matsuda Y, Ichida T. Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis. Med Mol Morphol. 2009;42:138\u201342.","journal-title":"Med Mol Morphol"},{"key":"1881_CR38","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1158\/0008-5472.CAN-18-2357","volume":"79","author":"SL Chen","year":"2019","unstructured":"Chen SL, Zhang CZ, Liu LL, Lu SX, Pan YH, Wang CH, et al. A GYS2\/p53 negative feedback loop restricts tumor growth in HBV-related hepatocellular carcinoma. Cancer Res. 2019;79:534\u201345.","journal-title":"Cancer Res"},{"key":"1881_CR39","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1128\/MCB.01189-12","volume":"33","author":"C Chan","year":"2013","unstructured":"Chan C, Wang Y, Chow PK, Chung AY, Ooi LL, Lee CG. Altered binding site selection of p53 transcription cassettes by hepatitis B virus X protein. Mol Cell Biol. 2013;33:485\u201397.","journal-title":"Mol Cell Biol"},{"key":"1881_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gene.2018.12.054","volume":"691","author":"X Wang","year":"2019","unstructured":"Wang X, Huo B, Liu J, Huang X, Zhang S, Feng T. Hepatitis B virus X reduces hepatocyte apoptosis and promotes cell cycle progression through the Akt\/mTOR pathway in vivo. Gene. 2019;691:87\u201395.","journal-title":"Gene."},{"key":"1881_CR41","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jhep.2019.01.007","volume":"70","author":"QG Xu","year":"2019","unstructured":"Xu QG, Yuan SX, Tao QF, Yu J, Cai J, Yang Y, et al. A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1\/STATs pathway in hepatocellular carcinoma. J Hepatol. 2019;70:904\u201317.","journal-title":"J Hepatol"},{"key":"1881_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.etp.2013.07.003","volume":"66","author":"MT Tasaki","year":"2014","unstructured":"Tasaki MT, Kuroiwa Y, Inoue T, Hibi D, Matsushita K, Kijima A, et al. Lack of nrf2 results in progression of proliferative lesions to neoplasms induced by long-term exposure to non-genotoxic hepatocarcinogens involving oxidative stress. Exp Toxicol Pathol. 2014;66:19\u201326.","journal-title":"Exp Toxicol Pathol"},{"key":"1881_CR43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0300-483X(01)00429-2","volume":"165","author":"SA Sheweita","year":"2001","unstructured":"Sheweita SA, Abd El-Gabar M, Bastawy M. Carbon tetrachloride-induced changes in the activity of phase II drug-metabolizing enzyme in the liver of male rats: role of antioxidants. Toxicology. 2001;165:217\u201324.","journal-title":"Toxicology."},{"key":"1881_CR44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jhep.2005.01.034","volume":"43","author":"M Domenicali","year":"2005","unstructured":"Domenicali M, Caraceni P, Principe A, Pertosa AM, Ros J, Chieco P, et al. A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. J Hepatol. 2005;43:92\u20137.","journal-title":"J Hepatol"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-021-01881-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-021-01881-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-021-01881-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T07:03:35Z","timestamp":1617260615000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-021-01881-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1881"],"URL":"https:\/\/doi.org\/10.1186\/s13046-021-01881-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-95103\/v1","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"16 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were conducted in accordance with the principles and procedures approved by the Committee on the Ethics of Animal Experiments of Peking University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reached an agreement to publish the study in this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}